199 related articles for article (PubMed ID: 21053377)
1. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.
Meyer MR; Du P; Schuster F; Maurer HH
J Mass Spectrom; 2010 Dec; 45(12):1426-42. PubMed ID: 21053377
[TBL] [Abstract][Full Text] [Related]
2. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
Meyer MR; Vollmar C; Schwaninger AE; Wolf E; Maurer HH
J Mass Spectrom; 2012 Feb; 47(2):253-62. PubMed ID: 22359337
[TBL] [Abstract][Full Text] [Related]
3. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
[TBL] [Abstract][Full Text] [Related]
4. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
Strano-Rossi S; Cadwallader AB; de la Torre X; Botrè F
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2706-14. PubMed ID: 20814976
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
6. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS.
Grapp M; Kaufmann C; Ebbecke M
Forensic Sci Int; 2017 Apr; 273():1-9. PubMed ID: 28187296
[TBL] [Abstract][Full Text] [Related]
7. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
[TBL] [Abstract][Full Text] [Related]
8. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
[TBL] [Abstract][Full Text] [Related]
9. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
[TBL] [Abstract][Full Text] [Related]
10. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Schmitt S; Maurer HH
J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
[TBL] [Abstract][Full Text] [Related]
11. Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS.
Meyer MR; Prosser D; Maurer HH
Drug Test Anal; 2013 Apr; 5(4):259-65. PubMed ID: 23303532
[TBL] [Abstract][Full Text] [Related]
12. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
[TBL] [Abstract][Full Text] [Related]
13. Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometry.
Mardal M; Meyer MR
Sci Total Environ; 2014 Sep; 493():588-95. PubMed ID: 24982024
[TBL] [Abstract][Full Text] [Related]
14. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.
Springer D; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):253-66. PubMed ID: 14581066
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
Welter J; Meyer MR; Kavanagh P; Maurer HH
Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
[TBL] [Abstract][Full Text] [Related]
19. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
[TBL] [Abstract][Full Text] [Related]
20. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
